These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38065599)

  • 1. ANCA-negative ANCA-associated vasculitis: pitfalls of the 'vasculitis screen'.
    Cooke H; Wells M; Miller K; Medford ARL; Patel S
    Clin Med (Lond); 2023 Nov; 23(6):630-632. PubMed ID: 38065599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic pachymeningitis in eosinophilic granulomatosis with polyangiitis.
    Izuka S; Yamashita H; Takahashi Y; Kaneko H
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):80-82. PubMed ID: 34480185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): Part 2 - Treatment of eosinophilic granulomatosis with polyangiitis and diagnosis and general management of AAV.
    Sanchez-Alamo B; Schirmer JH; Hellmich B; Jayne D; Monti S; Tomasson G; Luqmani RA
    RMD Open; 2023 Jun; 9(2):. PubMed ID: 37349121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ANCA-Associated Vasculitides].
    Stegert M; Neumann T; Daikeler T
    Ther Umsch; 2022 Jun; 79(5):229-237. PubMed ID: 35583025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe cardiomyopathy revealing antineutrophil cytoplasmic antibodies-negative eosinophilic granulomatosis with polyangiitis.
    Bouiller K; Samson M; Eicher JC; Audia S; Berthier S; Leguy V; Humbert O; Martin L; Lorgis L; Cottin Y; Bonnotte B; Lorcerie B
    Intern Med J; 2014 Sep; 44(9):928-31. PubMed ID: 25201426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilic granulomatosis with polyangiitis.
    Villa-Forte A
    Postgrad Med; 2023 Jan; 135(sup1):52-60. PubMed ID: 36259957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current landscape of antineutrophil cytoplasmic antibody-associated vasculitis: classification, diagnosis, and treatment.
    Lally L; Spiera R
    Rheum Dis Clin North Am; 2015; 41(1):1-19, vii. PubMed ID: 25399936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-targeted therapy for refractory eosinophilic granulomatosis with polyangiitis characterized by intracerebral hemorrhage and cardiomyopathy: a case-based review.
    Mutoh T; Shirai T; Sato H; Fujii H; Ishii T; Harigae H
    Rheumatol Int; 2022 Nov; 42(11):2069-2076. PubMed ID: 34287685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recommendations on the diagnosis and treatment of anti-neutrophil cytoplasmic antibody associated vasculitis in China].
    Tian XP; Zhao LK; Jiang ZY; Wang Y; Huang CB; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Oct; 61(10):1128-1135. PubMed ID: 36207967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis (AAV): a concise review with emphasis on clinical and histopathologic correlation.
    Gibson LE
    Int J Dermatol; 2022 Dec; 61(12):1442-1451. PubMed ID: 35599359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic granulomatosis with polyangiitis.
    Romero Gómez C; Hernández Negrín H; Ayala Gutiérrez MDM
    Med Clin (Barc); 2023 Apr; 160(7):310-317. PubMed ID: 36774291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of eosinophilic granulomatosis with polyangiitis during the clinical course of microscopic polyangiitis: A case report.
    Ide H; Shimizu T; Koike Y; Abe K; Shigematsu K; Nishihata S; Kojima K; Ichinose K; Kawakami A
    Medicine (Baltimore); 2022 Nov; 101(44):e31401. PubMed ID: 36343053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eosinophilic granulomatosis with polyangiitis : Update on classification and management].
    Hellmich B; Holle J; Moosig F
    Z Rheumatol; 2022 May; 81(4):286-299. PubMed ID: 35075511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulomatous Vasculitis.
    Sharma A; Dogra S; Sharma K
    Dermatol Clin; 2015 Jul; 33(3):475-87. PubMed ID: 26143427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overlap of granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
    Surendran S; Gundappa C; Gandhi A; Kurien AA; Fernando E
    Saudi J Kidney Dis Transpl; 2017; 28(3):639-644. PubMed ID: 28540906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].
    Jerrentrup A; Müller T; Mariss J; Dylla S
    Internist (Berl); 2018 May; 59(5):497-504. PubMed ID: 28983650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study.
    Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2024 Jan; 43(1):367-376. PubMed ID: 37530864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
    Frątczak A; Polak K; Miziołek B; Bergler-Czop B
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L43. Seropositive and negative ANCA-associated vasculitis, anti-MPO and PR3-vasculitis: different outcomes?
    Holle JU
    Presse Med; 2013 Apr; 42(4 Pt 2):616-9. PubMed ID: 23481358
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
    Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
    PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.